Company Eusol Biotech Co.,Ltd.

6652

TW0006652001

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Pharmaceuticals

End-of-day quote Taipei Exchange Other stock markets 18:00:00 2024-05-14 EDT			5-day change	1st Jan Change
8.11 ^TWD	0.00%		-4.48%	-14.27%

04-17	Eusol Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Eusol Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

EUSOL Biotech CO., LTD. is a Taiwan-based company mainly engaged in production of drugs. The Company is mainly engaged in the research, development and production of drugs. The Company is also engaged in cosmetics manufacturing business, drug testing business and western medicine retail business. The Company's main products include the protein drug ES135 and the small molecule compound drug SM-1. The Company distributes its products within domestic and overseas markets.

Managers	Title	Age	Since
Hong Jen Chang CEO	Chief Executive Officer	68	09-10-04
Chun Yue Lin DFI	Director of Finance/CFO	-	-
Wan Ya Chang BRD	Director/Board Member	-	-

Members of the board	Title	Age	Since
Shih Chang Hsu BRD	Director/Board Member	61	-
Hong Jen Chang CEO	Chief Executive Officer	68	09-10-04
Tsung Jen Yang BRD	Director/Board Member	-	18-06-14
Weng Foung Huang BRD	Director/Board Member	-	18-06-14
Hung Mo Li BRD	Director/Board Member	-	18-06-14
Wan Ya Chang BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	137,000,000	92,100,000 ( 67.23 %)	0	67.23 %

Eusol Biotech Co., Ltd.

6/F, No. 135, Section 3 Minsheng East Road

105 44, Taipei

http://www.eusol.com.tw

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
EUSOL BIOTECH CO.,LTD.	-14.27%	34.34M
NOVO NORDISK A/S	+31.37%	588B
JOHNSON & JOHNSON	-2.83%	364B
MERCK & CO., INC.	+20.52%	326B
ABBVIE INC.	+5.39%	285B
ASTRAZENECA PLC	+14.83%	239B
NOVARTIS AG	+9.93%	210B
ROCHE HOLDING AG	-6.95%	200B
AMGEN INC.	+10.89%	167B
PFIZER, INC.	+0.20%	161B

Other Pharmaceuticals